. 2015 Feb 18;10(2):e0118062. doi: 10.1371/journal.pone.0118062

Table 1. In vivo neutralization of HBV infection by monoclonal antibodies (mAbs).

HBV genotype	Group	HB0116 (μg/body)	HB0478 (μg/body)	HBV DNA (copies/mL)
C	Group 1	-	-	9.8 × 10³
	(n = 2)	-	-	1.1 × 10⁴
	Group 2	1	-	n.d.
	(n = 3)	1	-	n.d.
		1	-	n.d.
	Group 3	10	-	n.d.
	(n = 3)	10	-	n.d.
		10	-	n.d.
	Group 4	-	1	n.d.
	(n = 3)	-	1	n.d.
		-	1	n.d.
	Group 5	-	10	n.d.
	(n = 3)	-	10	n.d.
		-	10	n.d.
A	Group 6	1	-	n.d.
	(n = 3)	1	-	n.d.
		1	-	n.d.
	Group 7	10	-	n.d.
	(n = 3)	10	-	n.d.
		10	-	n.d.
	Group 8	-	1	n.d.
	(n = 3)	-	1	n.d.
		-	1	n.d.
	Group 9	-	10	n.d.
	(n = 2)	-	10	n.d.
G145R	Group 10	-	-	1.4 × 10⁴
	(n = 2)	-	-	1.0 × 10⁴
	Group 11	10	-	4.4 × 10⁴
	(n = 3)	10	-	1.1 × 10⁴
		10	-	3.3 × 10⁴
	Group 12	-	10	n.d.
	(n = 3)	-	10	n.d.
		-	10	n.d.
	Group 13	1	1	n.d.
	(n = 2)	1	1	n.d.
	Group 14	10	10	n.d.
	(n = 2)	10	10	n.d.
	Group 15	-	1	n.d.
	(n = 2)	-	1	n.d.

n.d.: not detected.